Research Paper Volume 13, Issue 7 pp 10450—10467

RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma


Figure 3. Gene set enrichment analysis between RIPK2 high- and low- expression samples. GSEA comparing gene-expression signatures of TCGA KIRC tumors with the RIPK2 high- and low-expression by using hallmark gene sets. GSEA positive result table (A) showing all the significant enrichment terms of the hallmark keg pathway gene sets from MSigDB, and GSEA negative result table (B) showing significant enrichment terms of the KEGG pathway gene sets from MSigDB.